Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (3): 983-990     DOI: 10.31083/j.rcm2203107
Special Issue: The treatment of mitral regurgitation in the 21st Century
Original Research Previous articles | Next articles
Echocardiographic and clinical outcomes of patients undergoing septal myectomy plus anterior mitral leaflet extension for hypertrophic cardiomyopathy
Rafle Fernandez1, Francesco Nappi2, Sofia A. Horvath1, Sarah A. Guigui1, Christos G. Mihos1, *()
1Echocardiography Laboratory, Columbia University Division of Cardiology, Mount Sinai Heart Institute, Miami Beach, FL 33140, USA
2Department of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, 93200 Paris, France
Download:  PDF(1342KB)  ( 194 ) Full text   ( 11 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Septal myectomy is indicated in patients with obstructive hypertrophic cardiomyopathy (HCM) and intractable symptoms. Concomitant mitral valve (MV) surgery is performed for abnormalities contributing to systolic anterior motion (SAM), or for SAM-mediated mitral regurgitation (MR) with or without left ventricular outflow tract (LVOT) obstruction. One MV repair technique is anterior mitral leaflet extension (AMLE) utilizing bovine pericardium, stiffening the leaflet and enhancing coaptation posteriorly. Fifteen HCM patients who underwent combined myectomy-AMLE for LVOT obstruction or moderate-to-severe MR between 2009 and 2020 were analyzed using detailed echocardiography. The mean age was 56.6 years and 67% were female. The average peak systolic LVOT gradient and MR grade measured 73.4 mmHg and 2.3, respectively. Indications for myectomy-AMLE were LVOT obstruction and moderate-to-severe MR in 67%, MR only in 20%, and LVOT obstruction only in 13%. There was no mortality observed, and median follow-up was 1.2 years. Two patients had follow-up grade 1 mitral SAM, one of whom also had mild LVOT obstruction. No recurrent MR was observed in 93%, and mild MR in 7%. Compared with preoperative measures, there was a decrease in follow-up LV ejection fraction (68.2 vs 56.3%, p = 0.02) and maximal septal wall thickness (25.5 vs 21.3 mm, p < 0.001), and an increase in the end-diastolic diameter (21.9 vs 24.8 mm/m2, p = 0.04). There was no change in global longitudinal strain (–12.1 vs –11.6%, p = 0.73) and peak LV twist (7.4 vs 7.3°, p = 0.97). In conclusion, myectomy-AMLE is a viable treatment option for carefully selected symptomatic HCM patients with LVOT obstruction or moderate-to-severe MR.
Key words:  HOCM      Hypertrophic cardiomyopathy      Mitral regurgitation      Mitral valve repair      Myectomy      Systolic anterior motion     
Submitted:  30 May 2021      Revised:  28 July 2021      Accepted:  29 July 2021      Published:  24 September 2021     
*Corresponding Author(s):  Christos.Mihos@msmc.com; drcmihos@gmail.com (Christos G. Mihos)   

Cite this article: 

Rafle Fernandez, Francesco Nappi, Sofia A. Horvath, Sarah A. Guigui, Christos G. Mihos. Echocardiographic and clinical outcomes of patients undergoing septal myectomy plus anterior mitral leaflet extension for hypertrophic cardiomyopathy. Reviews in Cardiovascular Medicine, 2021, 22(3): 983-990.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm2203107     OR     https://rcm.imrpress.com/EN/Y2021/V22/I3/983

[1] Matteo Beltrami, Simone Bartolini, Massimo Milli, Alberto Palazzuoli. The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 677-690.
[2] Amir Youssari, Jean-Paul Couetil, Mariantonietta Piscitelli, Céline Zerbib, Ophélie Brault-Meslin, Sanjeet Singh Avtaar Singh, Francesco Nappi, Antonio Fiore. The antegrade reperfusion test avoids the risk of mitral regurgitation recurrence optimizing valve repair[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 939-946.
[3] Francesco Nappi, Cristiano Spadaccio, Christos Mihos. Too much of a good thing in ischemic mitral: lessons for surgeons and cardiologists[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 259-261.
[4] Jong-Youn Kim, Eui-Young Choi, Wonho Kim, Se-Joong Rim. Left ventricular outflow obstruction occurs immediately after exercise in patients with non-obstructive hypertrophic cardiomyopathy[J]. Reviews in Cardiovascular Medicine, 2021, 22(2): 469-473.
[5] Walid MS. ElTahlawy, Tamer M. Ragab, Khaled A. Elkhashab, Hassan M. Ebeid. Quantification of mitral regurgitation using transthoracic echocardiography and cardiac magnetic resonance imaging[J]. Reviews in Cardiovascular Medicine, 2021, 22(1): 215-223.
[6] Juan M. Vinardell, Christos G. Mihos, Adam Nader, Richard Ro, Esteban Escolar, Orlando Santana. Stress Cardiomyopathy in a Patient with Hypertrophic Cardiomyopathy: Case Presentation and Review of the Literature[J]. Reviews in Cardiovascular Medicine, 2018, 19(2): 65-68.
[7] Georgios K. Efthimiadis, Efstathios Pagourelias, Thomas Zegkos, Despoina Parcharidou, Theofilos Panagiotidis, Alexandra Arvanitaki, Pavlos Rouskas, Haralambos Karvounis. An Overview of Pharmacotherapy in Hypertrophic Cardiomyopathy: Current Speculations and Clinical Perspectives[J]. Reviews in Cardiovascular Medicine, 2016, 17(3-4): 115-123.
[8] Leandro Slipczuk, Asim M. Rafique, Carlos D. Davila, Roy Beigel, Gregg S. Pressman, Robert J. Siegel. The Role of Medical Therapy in Moderate to Severe Degenerative Mitral Regurgitation[J]. Reviews in Cardiovascular Medicine, 2016, 17(1-2): 28-39.
[9] Marco Marchesini, Lucia Uguccioni, Rosario Parisi, Gianmaria Mattioli, Francesca Terzi, Roberto Olivieri, Alessandro Capucci, Rossella Fattori. The Role of Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy[J]. Reviews in Cardiovascular Medicine, 2016, 17(1-2): 57-64.
[10] Christos G. Mihos, Andres M. Pineda, Orlando Santana. Targeting the Papillary Muscles in Mitral Valve Repair for Ischemic Mitral Regurgitation[J]. Reviews in Cardiovascular Medicine, 2015, 16(3): 182-188.
[11] Olayinka Afolabi-Brown, D. Lynn Morris, Vincent M. Figueredo. Global T-wave Inversion on Electrocardiogram: What Is the Differential?[J]. Reviews in Cardiovascular Medicine, 2014, 15(2): 131-141.
[12] Jesse J. Naghi, Robert J. Siegel. Medical Management of Hypertrophic Cardiomyopathy[J]. Reviews in Cardiovascular Medicine, 2010, 11(4): 202-217.
[13] Syed Saghir, Tom D. Ivey, Dean J. Kereiakes, Wojciech Mazur. Anterior Mitral Valve Leaflet Aneurysm Due to Infective Endocarditis Detected by Cardiac Magnetic Resonance Imaging[J]. Reviews in Cardiovascular Medicine, 2006, 7(3): 157-159.
[14] . Best of the AHA Scientific Sessions 2003[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 26-52.
[15] Danita M. Yoerger, Arthur E. Weyman. Hypertrophic Obstructive Cardiomyopathy: Mechanism of Obstruction and Response to Therapy[J]. Reviews in Cardiovascular Medicine, 2003, 4(4): 199-215.
No Suggested Reading articles found!